Carlyle Group’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-131,036
Closed -$1.14M 28
2023
Q1
$1.14M Buy
+131,036
New +$1.14M 0.03% 25